Weight & Obesity

Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly prescribed once-a-week injection to manage diabetes) in lowering blood sugar levels, confirms a phase 3 randomized controlled trial […]

Navigating health care can be challenging under any circumstances, and systemic barriers can make the experience even more difficult for some groups. Weight-related stigma and inequities in health care can create barriers and negatively influence […]

The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight management.This article was originally published on MedicalXpress.com

Weight-loss interventions, including gastric bypass surgery and drugs that prevent dietary fat absorption, can be invasive or have negative side effects. Now, researchers have developed edible microbeads made from green tea polyphenols, vitamin E and […]

An international research team from Leibniz-FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging approach to track how popular dual agonist drugs like tirzepatide interact with cells in the […]

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s popular weight-loss drug Wegovy to treat a serious form of fatty liver disease.This article was originally published on MedicalXpress.com

Too much fat can be unhealthy: how fat cells, so-called adipocytes, develop, is crucial for the function of the fat tissue. That is why a team led by researchers from the University Hospital Bonn (UKB) […]

Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study published in the […]